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Background: Although primary treatment of localized prostate cancer provides excellent oncologic
control, some men who chose radiotherapy experience a recurrence of disease. There is no consensus on
the most appropriate management of these patients after radiotherapy failure. In this single-institution
review, we compare our oncologic outcome and toxicity between salvage prostatectomy and cryotherapy
treatments.
Methods: From January 2004 to June 2013, a total of 23 salvage procedures were performed. Six of those
patients underwent salvage prostatectomy while 17 underwent salvage cryotherapy by two high-volume
fellowship-trained urologists.
Patients being considered for salvage therapy had localized disease at presentation, a prostate-speciﬁc
antigen (PSA) < 10 ng/mL at recurrence, life expectancy > 10 years at recurrence, and a negative met-
astatic workup. Patients were followed to observe cancer progression and toxicity of treatment.
Results: Patients who underwent salvage cryotherapy were statistically older with a higher incidence of
hypertension than our salvage prostatectomy cohort. With a mean follow up of 14.1 months and
7.2 months, the incidence of disease progression was 23.5% and 16.7% after salvage cryotherapy and
prostatectomy, respectively. The overall complication rate was also 23.5% versus 16.7%, with the most
frequent complication after salvage cryotherapy being urethral stricture and after salvage prostatectomy
being severe urinary incontinence. There were no rectal injuries with salvage prostatectomy and one
rectourethral ﬁstula in the cohort after salvage cryotherapy.
Conclusion: While recurrences from primary radiotherapy for prostate cancer do occur, there is no
consensus on its management. In our experience, salvage procedures were generally safe and effective.
Both salvage cryotherapy and salvage prostatectomy allow for adequate cancer control with minimal
toxicity.
Copyright © 2015 Asian Paciﬁc Prostate Society, Published by Elsevier. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Prostate cancer is the most common cancer in males with an
estimated 230,000 patients diagnosed annually in the United
States.1 The therapeutic approach for clinically localized prostate
carcinoma is either surgery or radiation therapy, with approxi-
mately 25% newly diagnosed cases treated with radiotherapy with
active surveillance under therapeutic approaches.2sociates, 3801 International
ciﬁc Prostate Society, Published bAlthough primary treatment of localized prostate cancer pro-
vides oncologic control, some men who choose radiotherapy
experience a recurrence of disease. It has been estimated that up to
one third of patients will have local failure at 10 years with the
biochemical recurrence rate of approximately 63%.3
Patients who present with prostate cancer reoccurrence
conﬁned to the prostate may beneﬁt from salvage therapy. Current
recognized treatment options for recurrent prostate cancer include
prostatectomy, brachytherapy, high-intensity focused ultrasound,
and cryotherapy.1,4,5 However, because no ofﬁcial protocol exists
regarding optimal salvage therapy, there is no consensus on the
most appropriate management of these patients after radiotherapyy Elsevier. This is an open access article under the CC BY-NC-ND license (http://
Table 1
Perioperative Characteristics, Oncologic Outcomes, and Toxicities of Salvage Cryo-
therapy Versus Salvage Prostatectomy
Salvage
cryotherapy
(n ¼ 17)
Salvage
prostatectomy
(n ¼ 6)
P
Age (y) 71.6 ± 5.2 64.7 ± 8.4 0.03
% Caucasian 70.6% (12/17) 50.0% (3/6) 0.39
% African American 23.5% (4/17) 50.0% (3/6) 0.13
Preoperative PSA 5.27 ± 2.38 6.08 ± 3.43 0.55
Gleason score at diagnosis 6.8 ± 0.86 7.3 ± 0.52 0.18
Incidence of hypertension 70.6% (12/17) 16.7% (1/6) 0.02
Incidence of diabetes 23.5% (4/17) 16.7% (1/6) 0.74
Incidence of coronary heart disease 23.5% (4/17) 16.7% (1/6) 0.74
Biochemical recurrence 23.5% (4/17) 16.7% (1/6) 0.74
Follow up PSA 1.92 ± 2.6 1.42 ± 14.3 0.25
Total complication rate 23.5% (4/17) 16.7% (1/6) 0.74
Rate of urethral stricture 11.8% (2/17) 0.0% (0/6)
Rate of severe urinary incontinence 5.9% (1/17) 16.7% (1/6)
Rate of urethral ﬁstula 5.9% (1/17) 0.0% (0/6)
Rate of intraoperative rectal injury 0.0% (0/17) 0.0% (0/6)
PSA, prostate-speciﬁc antigen.
Prostate Int 4 (2016) 7e108failure. Previous studies within literature have investigated open
prostatectomy and robotic prostatectomy as options for salvage
therapy. Cryotherapy is considered a minimally-invasive salvage
procedure; however, our study considers robotic prostatectomy as
an appropriate option for a minimally-invasive approach for
salvage therapy. While many studies have proven both techniques
to be safe and effective, there are few studies which compare both.
In this single-institution review, we compare our oncologic
outcome and toxicity between salvage prostatectomy and cryo-
therapy treatments.
2. Materials and methods
From January 2004 to June 2013, a total of 23 salvage procedures
were performed. From this group, we identiﬁed six men who un-
derwent salvage prostatectomy, while 17 underwent salvage
cryotherapy by two high-volume fellowship-trained urologists.
Both options were presented to the patients and their preference
was used as the deciding factor. All patients underwent primary
local treatment for curative purposes for localized prostate cancer.
All surgeries were performed at Cleveland Clinic Florida. Preoper-
ative evaluation and postoperative follow-up were performed ac-
cording to institutional protocol. Patients being considered for
salvage therapy had localized disease at presentation, a prostate-
speciﬁc antigen (PSA) < 10 ng/mL at recurrence, life expectancy
> 10 years at recurrence, and a negative metastatic workup. Both
salvage cryotherapy and salvage prostatectomy were offered to
patients and choice of treatment was decided by the patient. Pa-
tients that underwent salvage procedures had a primary Gleason
score average between 6.8 for the cryotherapy group and 7.3 for the
prostatectomy group. The cutoff value of biochemical recurrence
following primary salvage therapy was two subsequent rises in PSA
> 6 months after reaching nadir. All patients had achieved PSA
nadir afterwards. We evaluated the following clinical variables: age,
race (white vs. nonwhite), and pre-initial treatment variables
including PSA and Gleason sum at original diagnosis. We observed
for a history of hypertension, coronary heart disease, or diabetes.
The primary outcomemeasurewas biochemical failure. In addition,
patients were subsequently followed to observe rate of urethral
stricture or urinary ﬁstula formation, and severity of urinary in-
continence. Patient data was performed retrospectively after
Institutional Review Board approval and analyzed with statistical
software. All tests were considered statistically signiﬁcant at
P < 0.05. Following the salvage treatment, disease progression was
based on PSA > 0.2 ng/mL.
2.1. Analysis
Statistical analysis used to conduct the tests was the two-tailed
t test and Chi-square test with SPSS statistical software, Armonk,
NY, USA.
3. Results
Within the cryotherapy group, 70.6% were Caucasian, 23.5%
were African American, and 5.9% was other. Within the prostatec-
tomy group, 50% were Caucasian and African American. With a
mean follow up of 14.1 months and 7.2 months, the incidence of
disease progression was 23.5% and 16.7% after salvage cryotherapy
and prostatectomy, respectively. The preoperative PSA value for the
cryotherapy group was 5.27 ng/mL and postoperatively PSA values
had a mean value of 1.42 ng/mL. The preoperative PSA value for the
prostatectomy group was 6.08 ng/mL and postoperatively PSA
values had a mean value of 1.92 ng/mL. The overall complication
rate was also 23.5% versus 16.7%, with the most frequentcomplication after salvage cryotherapy being urethral stricture
(11.8%) and after salvage prostatectomy being severe urinary in-
continence (16.7%). There were no rectal injuries with salvage
prostatectomy and one incidence of rectourethral ﬁstula in the
cohort after salvage cryotherapy (Table 1). Patients who underwent
salvage cryotherapy were statistically older with a higher incidence
of hypertension than our salvage prostatectomy cohort.
4. Discussion
The goal of salvage therapy for radioresistant prostate cancer is
to provide freedom from biochemical recurrence and avoid or delay
treatment with hormonal therapy. It is estimated that up to 63% of
men will experience biochemical recurrence within 10 years of
radiotherapy for localized prostate cancer.3 Possible mechanisms
include radiotherapy resistance of disease, failure to administer a
cytotoxic dose, and limitations in the ability to increase the dose to
limit side effects.6 Biochemical recurrence is deﬁned as a rise of
2 ng/mL or more above the nadir PSA.7 In addition, clinical suspi-
cion for reoccurrence is warranted when the patient presents with
new onset bladder outlet obstruction, hematuria, or palpable mass
on digital rectal exam.
Among the options for salvage therapy, radical prostatectomy is
attractive as it provides better staging information and assessment
and allows the opportunity to remove damaged radiated tissue.4,8
Despite this fact, salvage prostatectomy is not routinely per-
formed due to increased technical difﬁculty and increased risk of
urinary incontinence, rectal injury, and erectile dysfunction. When
robotic salvage prostatectomy was ﬁrst described by Jamal et al,9 it
was noted that the lateral and posterior anatomic planes were
obliterated from prior radiotherapy. Additional reports have noted
frequently encountering brachytherapy seeds outside the prostate
further obscuring dissection planes.10
Large series report the major complications from salvage pros-
tatectomy as bladder neck contractures (22%), urinary incontinence
(48%), and rectal injury (5%).11 Robotic salvage prostatectomy has
been demonstrated in one series with functional outcomes that are
comparable to a contemporary open Salvage Radical Prostatectomy
(SRP) series.11 A minimally invasive approach allows improved
visualization that allows an easier and safer dissection of the pos-
terior plane, which is often obliterated in patients with prior local
therapy. Finally, patients experienced low amounts of estimated
blood loss and one study reported no patients required perioper-
ative transfusion and endured a shorter length of stay.11 However,
Table 2
Comparison of Perioperative Complications From Salvage Therapy
Series No. of patients Salvage modality % Urethral stricture % Urinary incontinence % Urethral ﬁstula % Rectal injury
Ward et al11 89 Prostatectomy 23 56 NR 3
Stephenson et al4 60 Prostatectomy 32 68 NR 2
Our series 6 Prostatectomy 0 16.7 0 0
Pisters et al19 279 Cryoablation NR 10.2 1.2 NR
Donnelly et al16 46 Cryoablation 0 6.5 2.2 NR
De la Taille et al18 43 Cryoablation 5 9.0 NR NR
Our series 17 Cryoablation 11.8 5.9 5.9 0
NR, not recorded.
Vora et al / Radio-resistant prostate cancer 9robotic salvage surgery of the prostate requires prior experience in
radical prostatectomy due to the technically demanding nature of
the operation. A comparison of the complications among reviewed
studies is detailed in Table 2. In the small number of reported
studies, oncologic outcomes of salvage prostatectomy were a 10-
year PSA progression-free survival of 30e43% and a 10-year
cancer-speciﬁc survival rate of 70e77%.4,11,12 The overall positive
surgical margin rate over all studies reviewed was 24.7% (21/89)
and the biochemical recurrence rate was 24.7% (21/85).13
Cryotherapy has been employed as a salvage intervention due to
comparable oncologic outcomes and complication rates and less
challenging technical components than salvage prostatectomy.14 In
particular, third generation technology has allowed better evalua-
tion of the prostate and the surrounding structures, and permitted
accurate placement of the percutaneous catheters to allow safer
surgery with better oncologic outcomes.15 Donnelly et al16
demonstrated that patients can achieve biochemical disease-free
status after salvage cryotherapy which is durable at 12 months
and 24 months. Complications from cryotherapy are more preva-
lent in patients undergoing salvage therapy, with reported rates of
73% and 72% for urinary incontinence and erectile dysfunction,
respectively.17e19 Other reported complications include rectal pain,
intractable dysuria, recurrent urinary tract infections, and urethral
ﬁstulae.16
A recent analysis compared the effectiveness of salvage cryo-
therapy and prostatectomy. In an analysis of > 345,000 patients in
the Surveillance, Epidemiology, and End Results (SEER) database,
341 underwent salvage cryoablation and 99 patients underwent
salvage prostatectomy. The results showed a trend towards
increased overall and cancer speciﬁcmortality in the prostatectomy
cohort when compared to those who had cryoablation.14 This dif-
fers from a retrospective single-center study published in 2009
which showed better overall survival with salvage prostatectomy
but comparable cancer speciﬁc survival.20
Our study is the ﬁrst which compares salvage cryotherapy with
salvage robotic prostatectomy at a single institution. Our results are
similar to those published in 2009 in that salvage prostatectomy
offered a lower rate of biochemical recurrence than cryotherapy.
Additionally, perioperative complications were lower in the
prostatectomy cohort. Limitations of our study include our small
sample size and short length of follow up. Our single-institution
study and our data may not be generalizable. However, this series
provides important information in support of a robotic prostatec-
tomy minimally invasive approach for recurrent prostate cancer
after failed primary therapy. In addition, our study provides sup-
porting evidence for a minimally invasive approach for salvage
therapy compared to standard open prostatectomy. Additional
studies will be needed to validate our ﬁndings.
While recurrences from primary radiotherapy for prostate
cancer do occur, there is no consensus on its management. In our
experience, salvage procedures were generally safe and effective.
Both salvage cryotherapy and salvage robotic prostatectomy allow
for adequate cancer control with minimal toxicity, which a trendtowards better oncologic and functional outcomes with robotic
salvage prostatectomy. Limitations of our study include the limited
length of follow up and conclusions derived from such. Despite this,
we found that tolerability is better with robotic procedures. With
the nature of the operation being technically challenging, we rec-
ommended they be performed by surgeons with prior high volume
experiencewith radical prostatectomy.Whenmastered, it can be as
tolerable to patients as outpatient cryoablation.
Our single institution study compares the effects of two types of
minimally invasive salvage procedures: robotic prostatectomy
versus cryotherapy. We observed safe and favorable outcomes of
robotic prostatectomy with outcomes comparable to open salvage
radical prostatectomy. Observed beneﬁts of a robotic approach
include improved visualization of the posterior dissection plane,
low complication rates, reported low blood loss, and decreased
hospital stay. We recommend further follow up and studies to
determine the usefulness of this approach.Conﬂicts of interest
All contributing authors declare no conﬂicts of interest.References
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